Understand the source comparison
The BDNF vs GABA Mechanism Split
The core distinction in peptides for depression research compared comes down to target pathway: neurotrophic signaling or GABAergic modulation. Semax operates as an ACTH(4-10) analogue that crosses the blood-brain barrier and upregulates neurotrophin expressio
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The core distinction in peptides for depression research compared comes down to target pathway: neurotrophic signaling or GABAergic modulation. Semax operates as an ACTH(4-10) analogue that crosses the blood-brain barrier and upregulates neurotrophin expression. Specifically BDNF, NGF (nerve growth factor), and VEGF (vascular endothelial growth factor). BDNF activates TrkB receptors on neurons, triggering intracellular cascades (PI3K/Akt, MAPK/ERK) that increase synaptic protein synthesis and dendritic spine density. A 2020 study in Frontiers in Pharmacology demonstrated Semax administration restored hippocampal BDNF levels to baseline in chronic stress models within 14 days. Timelines conventional SSRIs require 4–6 weeks to approach.
- Selank takes a completely different route: it's a synthetic analogue of tuftsin (Thr-Lys-Pro-Arg) engineered with additional amino acids to resist enzymatic degradation. It doesn't boost BDNF. Instead, it modulates GABAergic neurotransmission by inhibiting enkephalin breakdown. Endogenous opioid peptides that bind to delta and mu receptors. This produces anxiolytic effects without the sedation, tolerance, or dependence associated with benzodiazepines. Research published in the Journal of Psychopharmacology showed Selank reduced anxiety biomarkers (IL-6, cortisol) by 23–31% in generalized anxiety disorder models without impacting motor function or memory consolidation.
- P21, derived from a 11-residue sequence of CREB (cAMP response element-binding protein), activates the same transcription factor pathways that ketamine's rapid antidepressant effects depend on. But without NMDA receptor antagonism. It penetrates neurons and directly enhances CREB phosphorylation, which drives expression of genes involved in synaptic plasticity and hippocampal neurogenesis. Unlike Semax or Selank, P21 research focuses on reversing stress-induced neuronal atrophy in the CA1 and CA3 hippocampal regions, areas where MDD patients show consistent structural deficits on MRI.